|Bid||11.95 x 800|
|Ask||12.10 x 1800|
|Day's range||11.75 - 12.18|
|52-week range||7.08 - 40.91|
|Beta (5Y monthly)||2.24|
|PE ratio (TTM)||N/A|
|Earnings date||13 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||28 Aug 1996|
|1y target est||12.00|
VIENNA, Va., August 16, 2021--CEL-SCI Corporation reports third quarter fiscal 2021 financial results.
The company attempted to clarify "confusion" related to its recent late-stage clinical results.
VIENNA, Va., July 07, 2021--CEL-SCI Corporation issues letter to shareholders.